These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 18326583)
1. Topological mapping of the asymmetric drug binding to the human ether-à-go-go-related gene product (HERG) potassium channel by use of tandem dimers. Myokai T; Ryu S; Shimizu H; Oiki S Mol Pharmacol; 2008 Jun; 73(6):1643-51. PubMed ID: 18326583 [TBL] [Abstract][Full Text] [Related]
2. Docking model of drug binding to the human ether-à-go-go potassium channel guided by tandem dimer mutant patch-clamp data: a synergic approach. Imai YN; Ryu S; Oiki S J Med Chem; 2009 Mar; 52(6):1630-8. PubMed ID: 19260734 [TBL] [Abstract][Full Text] [Related]
3. Refining insights into high-affinity drug binding to the human ether-à-go-go-related gene potassium channel. Hancox JC; James AF Mol Pharmacol; 2008 Jun; 73(6):1592-5. PubMed ID: 18381562 [TBL] [Abstract][Full Text] [Related]
4. Drug binding to the inactivated state is necessary but not sufficient for high-affinity binding to human ether-à-go-go-related gene channels. Perrin MJ; Kuchel PW; Campbell TJ; Vandenberg JI Mol Pharmacol; 2008 Nov; 74(5):1443-52. PubMed ID: 18701618 [TBL] [Abstract][Full Text] [Related]
5. Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain. Duan JJ; Ma JH; Zhang PH; Wang XP; Zou AR; Tu DN Acta Pharmacol Sin; 2007 Jul; 28(7):959-67. PubMed ID: 17588331 [TBL] [Abstract][Full Text] [Related]
6. Block of hERG channel by ziprasidone: biophysical properties and molecular determinants. Su Z; Chen J; Martin RL; McDermott JS; Cox BF; Gopalakrishnan M; Gintant GA Biochem Pharmacol; 2006 Jan; 71(3):278-86. PubMed ID: 16325148 [TBL] [Abstract][Full Text] [Related]
7. Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers. Zachariae U; Giordanetto F; Leach AG J Med Chem; 2009 Jul; 52(14):4266-76. PubMed ID: 19534531 [TBL] [Abstract][Full Text] [Related]
8. In vitro modulation of HERG channels by organochlorine solvent trichlormethane as potential explanation for proarrhythmic effects of chloroform. Scholz EP; Alter M; Zitron E; Kiesecker C; Kathöfer S; Thomas D; Kreye VA; Kreuzer J; Becker R; Katus HA; Greten J; Karle CA Toxicol Lett; 2006 Aug; 165(2):156-66. PubMed ID: 16647228 [TBL] [Abstract][Full Text] [Related]
9. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels. Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732 [TBL] [Abstract][Full Text] [Related]
10. Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels. Guo J; Gang H; Zhang S J Pharmacol Exp Ther; 2006 May; 317(2):865-74. PubMed ID: 16397089 [TBL] [Abstract][Full Text] [Related]
11. [HERG K+ channel, the target of anti-arrhythmias drugs]. Guan FY; Yang SJ Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949 [TBL] [Abstract][Full Text] [Related]
12. Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking. Wang L; Wible BA; Wan X; Ficker E J Pharmacol Exp Ther; 2007 Feb; 320(2):525-34. PubMed ID: 17095614 [TBL] [Abstract][Full Text] [Related]
13. The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells. Tang Q; Jin MW; Xiang JZ; Dong MQ; Sun HY; Lau CP; Li GR Biochem Pharmacol; 2007 Dec; 74(11):1596-607. PubMed ID: 17826747 [TBL] [Abstract][Full Text] [Related]
14. APETx1 from sea anemone Anthopleura elegantissima is a gating modifier peptide toxin of the human ether-a-go-go- related potassium channel. Zhang M; Liu XS; Diochot S; Lazdunski M; Tseng GN Mol Pharmacol; 2007 Aug; 72(2):259-68. PubMed ID: 17473056 [TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of hERG channel block by terfenadine and cisapride. Kamiya K; Niwa R; Morishima M; Honjo H; Sanguinetti MC J Pharmacol Sci; 2008 Nov; 108(3):301-7. PubMed ID: 18987434 [TBL] [Abstract][Full Text] [Related]
16. Analogs of MK-499 are differentially affected by a mutation in the S6 domain of the hERG K+ channel. Karczewski J; Wang J; Kane SA; Kiss L; Koblan KS; Culberson JC; Spencer RH Biochem Pharmacol; 2009 May; 77(10):1602-11. PubMed ID: 19426697 [TBL] [Abstract][Full Text] [Related]
17. Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain. Durdagi S; Duff HJ; Noskov SY J Chem Inf Model; 2011 Feb; 51(2):463-74. PubMed ID: 21241063 [TBL] [Abstract][Full Text] [Related]
18. Interaction simulation of hERG K+ channel with its specific BeKm-1 peptide: insights into the selectivity of molecular recognition. Yi H; Cao Z; Yin S; Dai C; Wu Y; Li W J Proteome Res; 2007 Feb; 6(2):611-20. PubMed ID: 17269718 [TBL] [Abstract][Full Text] [Related]
19. Block of the hERG channel by bupivacaine: Electrophysiological and modeling insights towards stereochemical optimization. Sintra Grilo L; Carrupt PA; Abriel H; Daina A Eur J Med Chem; 2011 Aug; 46(8):3486-98. PubMed ID: 21624711 [TBL] [Abstract][Full Text] [Related]
20. Effect of S5P alpha-helix charge mutants on inactivation of hERG K+ channels. Clarke CE; Hill AP; Zhao J; Kondo M; Subbiah RN; Campbell TJ; Vandenberg JI J Physiol; 2006 Jun; 573(Pt 2):291-304. PubMed ID: 16556651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]